CITADEL ADVISORS LLC

Q2 2020 13F-HR Detailed Holdings

Location
Chicago, IL
Holdings as of
6/30/2020
Date filed
8/14/2020
Form type
13F-HR
Num holdings
11,802
Total value ($000)
$280,432,841
Net value change ($000)
+57,956,738 (26.1%)
New positions
824
Sold out positions
1030
Turnover %
13.5%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AMZN 1,317,931 163.5%
AAPL 561,087 347.1%
TMUS 432,324 157.9%
JPM 347,691 1943.0%
AON 311,961 NEW
BAC 292,314 8507.4%
BMY 280,601 381.1%
IEMG 278,633 5034.0%
BDX 266,202 NEW
SIRI 231,038 421.9%
Top Reduces (Value $000, Stocks/ETFs)
Allergan plc -602,572 -100.0%
FIS -441,779 -70.4%
CHTR -387,127 -54.6%
BAX -336,399 -97.0%
LQD -307,040 -88.3%
QQQ -305,597 -54.4%
MCK -284,302 -68.1%
BSX -279,059 -98.9%
BND -242,925 -100.0%
BIV -241,188 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 207,291,861 (73.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Citadel Securities GP LLC 28-18870